CaV1.2 N‐terminal Splice Variants Regulate Cerebral Artery Diameter

John Philip Bannister,Candice Thomas,Adebowale Adebiyi,Xiaoyang Cheng,Guiling Zhao,Jonathan Harvey Jaggar
DOI: https://doi.org/10.1096/fasebj.24.1_supplement.985.9
2010-01-01
Abstract:Voltage‐dependent Ca2+ (Cav1.2) channels are the major Ca2+ entry pathway in arterial myocytes and are essential for myogenic constriction. Alternative splicing of CaV1.2 α1 subunit exon 1 generates two different N‐terminal variants in arterial myocytes (CaV1.2e1b and CaV1.2e1c). Here, we examined physiological functions of Cav1.2 α1 subunit N‐terminal splice variants in cerebral artery myocytes. Acute application of a membrane‐permeant peptide corresponding to the CaV1.2e1c N‐terminus inhibited myocyte voltage‐dependent Ba2+ currents and reversibly dilated pressurized arteries. Overexpression of the exon1‐encoded N‐terminus of CaV1.2e1b or CaV1.2e1c reduced pressure‐induced vasoconstriction (myogenic tone). shRNA targeting exon 1b selectively reduced CaV1.2e1b by ~39% and myogenic tone (at 60 mmHg) by ~34%. shRNA to exon 1c selectively reduced CaV1.2e1c by ~62% and myogenic tone by ~57%. shRNA targeting α2δ‐1, a CaV1.2 auxiliary subunit, reduced α2δ‐1 by ~57 % and plasma membrane‐localized (measured using biotinylation) CaV1.2e1b by ~54% and CaV1.2e1c by ~35%. Data indicate that both CaV1.2e1b and CaV1.2e1c modulate cerebral artery diameter and that α2δ‐1 differentially regulates plasma membrane trafficking of CaV1.2 N‐terminus variants. NIH HL67061, HL094378.
What problem does this paper attempt to address?